Recent Finacing
Recent Raise
ASIT Biotech is a Belgian clinical-stage biopharmaceutical developing ASIT+ immunotherapies—optimized purified allergen fragment mixtures—for respiratory and food allergies, collaborating with Imperial College and King's College, headquartered in Brussels.
Focus Areas
Total Raised
Funding round